Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Jose Baselga
Based on 154 articles published since 2008
||||
Expertise Level
The expertise of Jose Baselga ranks in the
  • Top 0.0031%
  • ... of 257,180 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 154 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Baselga, José   ·   Baselga, J   ·   Baselga, Jose
Work Locations
Details
Most likely:    Memorial Sloan-Kettering Cancer Center   Contact    
2018
  • Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. Electronic address: · Frontier Science (Scotland) Ltd., Kincraig, UK. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. · IRCCS A.O.U. S.Martino-IST, Genoa, Italy. · European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast International Group (BIG), Brussels, Belgium. · Instituto de Oncologia de Rosário, Rosário, Argentina. · Clinica de Oncologia, Porto Alegre, Brazil. · Queen Elizabeth Hospital, Hong Kong, China. · Istituto Europeo di Oncologia, Milan, Italy. · Ospedale di Trento, Trento, Italy. · Oslo University Hospital, Oslo, Norway. · The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom. · Ulm University Hospital, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29227816
2017
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States. · University of Sheffield, Weston Park Hospital, Sheffield, United Kingdom. Electronic address: · Ramón y Cajal University Hospital, Madrid, Spain. · University of Ulm, Ulm, Germany. · Pubmed 29042085
  • German Breast Group, Neu-Isenburg, Germany; Sana-Klinikum Offenbach, Germany. Electronic address: · SOLTI Breast Cancer Research Group, Barcelona, Spain. · German Breast Group, Neu-Isenburg, Germany. · Breast International Group, Brussels, Belgium. · Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Villejuif, France; CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Institute of Pathology, Charité University Hospital, Berlin, Germany. · Luisenkrankenhaus Düsseldorf, Germany. · Hospital Clinico Universitario de Valencia, Spain. · Helios Klinikum Berlin-Buch, Department of Obstetrics and Gynaecology, Berlin, Germany. · Department of Haematology-Oncology, National University Cancer Institute, Singapore. · Novartis Pharma SAS, Rueil Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Kliniken Essen-Mitte, Essen, Germany. · Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, Austria; Comprehensive Cancer Center Vienna, Austria. · Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · University Breast Centre of Franconia, OBGYN Department, University Hospital Erlangen, CCC Erlangen-EMN, Germany. · Breast International Group, Brussels, Belgium; Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · SOLTI Breast Cancer Research Group, Barcelona, Spain; Memorial Sloan-Kettering Cancer Center, New York, USA. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Australian New Zealand Breast Cancer Trials Group (ANZBCTG), Newcastle, Australia. Electronic address: · Pubmed 28923573
  • Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · Seoul National University College of Medicine, Seoul, Republic of Korea. · National Taiwan University Hospital, Taipei, Taiwan. · Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Moores Cancer Center, University of California at San Diego, La Jolla, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Huntsman Cancer Institute, Salt Lake City, UT, USA. · Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. · University of Chicago, Chicago, IL, USA. · City of Hope, Department of Medical Oncology and Therapeutics Research, Duarte, CA, USA. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pfizer Inc., New York, NY, USA. · Novartis Institutes for BioMedical Research, Cambridge, MA, USA. · Pubmed 28899363
  • Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: · S. Orsola Malpighi Hospital, Bologna, Italy. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Hospital Clínico Universitario de Valencia, Valencia, Spain. · Saitama Cancer Center, Saitama, Japan. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · Curtin Health Innovation Research Institute, Curtin University, Perth, Australia. · University of Pécs, Pécs, Hungary. · Karolinska Institutet and University Hospital, Stockholm, Sweden. · Hospital Sírio Libanês, São Paulo, Brazil. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Northwestern University Feinberg School of Medicine, Chicago, IL. · Memorial Sloan Kettering Cancer Center, New York, NY. · The Medical Oncology Center of Rosebank and Linksfield Park Hospital, Johannesburg, South Africa. · Institut Claudius Régaud, Toulouse, France. · Bayer HealthCare Pharmaceuticals, Whippany, NJ. · The West Clinic, Memphis, TN. · Pubmed 28830796
  • Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: · Division of Medical Oncology, National Cancer Centre, Singapore, Singapore. · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Breast Disease Center, Hospital Saint Louis, Paris, France. · Northwest Medical Specialties and Division of Oncology, University of Washington, Washington, WA, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Massachusetts General Hospital, Boston, MA, USA. · Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Genentech Inc, South San Francisco, CA, USA. · Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28800861
  • UCSF Helen, Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Centre Léon Bérard, Lyon, France. · National Cancer Center, Goyang, Republic of Korea. · H. de Lleida Arnau de Vilanova, Lerida, Spain. · Institut de Cancérologie de l'Ouest, St Herblain-Nantes, France. · University Hospital of Parma, Parma, Italy. · Instituto Português de Oncologia Francisco Gentil, Porto, Portugal. · Korea University Medical Center, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Merck& Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · Alexion Pharmaceuticals, New Haven, CT, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28681171
  • Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain. · Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada. · Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Department of Oncology, Ospedale di Macerata, Macerata, Italy. · Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. · Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium. · Novartis Pharma SAS, Paris, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Syros Pharmaceuticals, Watertown, MA, USA. · Novartis Pharma AG, Basel, Switzerland. · Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. · Pubmed 28576675
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of California San Francisco Comprehensive Cancer Center, San Francisco, California. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Institut Curie, Paris, France. · Texas Oncology, Austin, Texas. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center, New York, New York. · Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, Tennessee. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28533223
  • Department of Medical Oncology, Institut Curie, Paris, France. Electronic address: · Mount Vernon Cancer Centre, Northwood, UK. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Stanford Cancer Institute, Palo Alto, CA, USA. · Medical Office Hematology, Aschaffenburg, Germany. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Duke University Medical Center, Durham, NC, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Genentech Inc, South San Francisco, CA, USA. · San Raffaele Hospital, Milan, Italy. · Pubmed 28526536
  • Memorial Sloan Kettering Cancer Center, New York, NY, USA. · H. de Lleida Arnau de Vilanova, Lérida, Spain. · Institut Jules Bordet, Brussels, Belgium. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Ramon y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Massachusetts General Hospital, Boston, MA, USA. · Mayo Clinic, Rochester, MN, USA. · University of Minnesota Masonic Clinical Cancer Center, Minneapolis, MN, USA. · Hospital 12 de Octubre, Madrid, Spain. · Clinique Sainte Elisabeth, Namur, Belgium. · Merck & Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St., San Francisco, CA, USA. · Pubmed 28324268
  • University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. Electronic address: · Department of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · Frontier Science Scotland Ltd, Kincraig, Kingussie, UK. · European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. · Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Helios Klinikum Berlin Buch, Multidisciplinary Breast Cancer Center, Berlin, Germany. · Breast Unit, Royal Marsden Hospital, and The Institute of Cancer Research, London, UK. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Avera Cancer Institute Center for Precision Oncology, Sioux Falls, SD, USA. · Deakin University, Waurn Ponds, VIC, Australia. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Pubmed 28215665
  • Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA. · National Center for Tumor Diseases, University Hospital Heidelberg, Germany. · Department of Gynecology and Obstetrics, University Hospital Heidelberg, Heidelberg, Germany. · Department of Medical Oncology, San Raffaele Hospital, Milan, Italy. · Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, MA, USA. · BioOncology, Genentech, Inc., South San Francisco, CA, USA. · Clinical Development, Roche Products Ltd, Welwyn Garden City, UK. · Biostatistics, Genentech, Inc., South San Francisco, CA, USA. · Ramon y Cajal University Hospital, Madrid, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 28057664
  • Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Radiology and Radiological Science, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Genentech, Inc., South San Francisco, California. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28011460
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
  • Breast Cancer Program, Istituto Europeo di Oncologia, Milano, Italy. · Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Klinik St. Anna, Luzern, Switzerland. · German Breast Group, Neu-Isenburg, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Medical Oncology, Institut Jules Bordet, UniversitÕ Libre de Bruxelles, Brussels, Belgium. · Tumor and Breast Center ZeTuP, St. Gallen. · Breast Center, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Institut de Cancérologie Gustave Roussy, Villejuif, France. · Memorial Sloan Kettering Cancer Center, New York, USA. · Karolinska Institute and University Hospital, Stockholm, Sweden. · University of Bordeaux, Bordeaux, France. · Universitäts-Frauenklinik Tübingen, Tübingen, Germany. · Champalimaud Cancer Centre, Lisbon, Portugal. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany. · Azienda Usl Toscana Centro, Prato, Italy. · Rigshospitalet, Copenhagen, Denmark. · Peter McCallum Cancer Centre, Melbourne, Australia. · Marmara University School of Medicine, Istanbul, Turkey. · University of Toronto, Mount Sinai Hospital, Toronto, Canada. · University of Munich, München, Germany. · Comprehensive Cancer Center, University of Michigan, Ann-Arbor, USA. · National Taiwan University Hospital, Taipei, Taiwan. · University of Ulm, Ulm, Germany. · The National Cancer Institute, Cairo University, Cairo, Egypt. · Medical University of Gdansk, Gdansk, Poland. · Hospital Affiliated to Military Medical Science, Beijing, China. · Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden. · Baylor College of Medicine, Houston, USA. · Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Canada. · National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria. · N.N. Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Fudan University Cancer Hospital, Shanghai, China. · The Royal Marsden, Sutton, Surrey, UK. · Graduate School of Medicine Kyoto University, Sakyo-ku, Kyoto City, Japan. · Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK. · University of Milan, Milan. · Istituto Europeo di Oncologia, Milan, Italy. · Hamamatsu Oncology Center, Hamamatsu, Japan. · McMaster University, Hamilton, Canada. · National Cancer Center, Chaoyang District, Beijing, China. · Pubmed 28838210
  • The Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02124, USA. · Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts 02129, USA. · Division of Health Sciences and Technology, MIT, Cambridge, Massachusetts 02139, USA. · Instituto de Enfermedades de la Mama FUCAM, A.C., Mexico City 04980, Mexico. · Princess Margaret Cancer Centre, University Health Network and the Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada. · Harvard Medical School, Boston, Massachusetts 02115, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico. · Massachusetts General Hospital, Department of Pathology, Boston, Massachusetts 02114, USA. · Pubmed 28658208
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Prometheus Laboratories, San Diego, California. · Foundation Medicine, Cambridge, Massachusetts. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Department of Gynecology, University of Ulm, Ulm, Germany. · Novartis Pharmaceuticals, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Pubmed 28381415
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Computational Biology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 460, New York, NY 10065, USA. · Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, 1450 3rd Street, San Francisco, CA 94158, USA. · Microchemistry and Proteomics Core Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 28336670
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Oncology Precision Medicine, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA. · Global Medical Affairs, Novartis Pharma AG, Basel CH-4002, Switzerland. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 28183140
  • Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science, Inverness, Scotland. · Breast Center, Department of Obstetrics and Gynecology, University of Munich, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Hospital Moinhos de Vento, Porto Alegre, Brazil. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · The Christie/NIHR Clinical Research Facility, Manchester, UK. · Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · Novartis, Cambridge. · Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, USA. · Pubmed 28177460
  • Memorial Sloan Kettering Cancer Center, New York, New York, USA · Department of Surgery, Beth Israel Deaconess Medical Center, Harvard School of Medicine, Boston, Massachusetts, USA. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Clínica de Oncologia (CLION), Clínica de Assistência à Mulher (CAM) Group, Salvador, Bahia, Brazil. · Pubmed 28167568
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · AstraZeneca, iMED Oncology, Cambridge, UK. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · AstraZeneca, Discovery Sciences, IMED Biotech Unit, Cambridge, UK. · AstraZeneca, iMED Oncology, Waltham, Massachusetts. · Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois. · Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois. · Weill Cornell Medical College, New York, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27986707
2016
  • Memorial Sloan Kettering Cancer Center (MSKCC), Human Oncology and Pathogenesis Program (HOPP), NY, USA. · Unit of Investigative Clinical Oncology, Institute for Cancer Research and Treatment, Candiolo, Italy. · Bioinformatics Institute (A*STAR), #07-01 Matrix, 30 Biopolis Street #07-01, 138671, Singapore. · Medical Oncology, Ospedale Civile di Saluzzo, Saluzzo, Italy. · Bioinformatics Institute (A*STAR), #07-01 Matrix, 30 Biopolis Street #07-01, 138671, Singapore; Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, 117543, Singapore; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore. · Memorial Sloan Kettering Cancer Center (MSKCC), Human Oncology and Pathogenesis Program (HOPP), NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Memorial Sloan Kettering Cancer Center (MSKCC), Human Oncology and Pathogenesis Program (HOPP), NY, USA. Electronic address: · Pubmed 26645663
  • Breast Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY, 10065, USA. · Breast Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY, 10065, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA. · NewYork-Presbyterian/Lawrence Hospital, New York, USA. · CLION, Salvador, Brazil. · Pubmed 27306421
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Genentech, Inc., South San Francisco, California. · Sunnybrook Odette Cancer Centre, Toronto, Canada. · National Cancer Center, Goyang, Korea. · Breast Center, Kantonsspital St. Gallen, St. Gallen, Switzerland. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · Stanford Cancer Institute, Palo Alto, California. · Pubmed 26920887
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26454612
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain; Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Universitat Autonoma de Barcelona, 08035 Barcelona, Spain. · Department of Structural Immunology, Institute of Innate Immunity, University of Bonn, 53127 Bonn, Germany; Group Physical Biochemistry, Center of Advanced European Studies and Research, 53175 Bonn, Germany. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Radiation Oncology and Center for DNA Damage and Repair, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital and Harvard Medical School, Boston, MA 02215, USA. · Developmental Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent's Health Network, Darlinghurst, NSW 2010, Australia. · Department of Radiation Oncology and Center for DNA Damage and Repair, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; Department of Medicine, Harvard Medical School, Boston, MA 02114, USA. · Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Universitat Autonoma de Barcelona, 08035 Barcelona, Spain. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent's Health Network, Darlinghurst, NSW 2010, Australia. Electronic address: · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: · Pubmed 27880910
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · DNA Damage Response Biology Area, Oncology IMED, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK. · OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. · Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY 10065, USA. · Translational Research Department, Institut Curie, 26 rue d'Ulm, Paris 75005, France. · Huntsman Cancer Institute, Salt Lake City, UT 84112, USA. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 27641504
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · The Broad Institute of MIT and Harvard, Cambridge, MA. · Division of Hematology Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston MA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, NewYork, NY. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine, Brigham and Women's Hospital, Boston MA. · Pubmed 27604488
  • CIC bioGUNE, Bizkaia Technology Park, Bulding 801a, 48160 Derio, Spain. · Oncology Programme, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · Oncology Area, Biodonostia Institute, 20014 San Sebastian, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. · ERTICa Research Group, University of Auvergne EA4677, Clermont-Ferrand, France. · Biodiagnostics Laboratory OncoGenAuvergne, Pathology Unit, Jean Perrin Comprehensive Cancer Center, 63000 Clermont-Ferrand, France. · Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 13288 Marseille, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). · IKERBASQUE, Basque foundation for science, 48013 Bilbao, Spain. · Experimental Therapeutics Group, Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Weill Cornell Medicine, New York 10021, USA. · Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), 48949 Leioa, Spain. · Pubmed 27553708
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · University of Texas MD Anderson Cancer Center, Houston. · Pubmed 27532364
  • MRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences University of Dundee, Dundee, UK · MRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences University of Dundee, Dundee, UK. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Oncology iMED, AstraZeneca CRUK Cambridge Institute, Cambridge, UK. · Department of Biochemistry, Institute of Integrative Biology University of Liverpool, Liverpool, UK. · Pubmed 27481935
  • German Breast Group, Neu-Isenburg, Germany · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Surgery, Oncology and Gastroenterology, University of Padua, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · German Breast Group, Neu-Isenburg, Germany. · Frontier Science Scotland, Kincraig, UK. · Department of Medical Oncology, University of Verona, Verona, Italy. · Institute of Pathology, Charité Universitätsmedizin Berlin, and German Cancer Consortium (DKTK), Berlin. · Department of Obstetrics and Gynecology, University Hospital Kiel, Kiel, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussel, Belgium. · Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Obstetrics and Gynecology, Helios-Klinikum, Berlin-Buch, Germany. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 27177864
  • The Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Weill Cornell Medicine, Cornell University, New York, New York. · Medical Oncology, Hospital Vall d'Hebron, Spain. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · The Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom. Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom. · The Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom. Breast Unit, Royal Marsden Hospital, London, United Kingdom. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 27020857
  • Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, New York, New York. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26957555
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Pathology, Hospital Israelita Albert Einstein, Instituto Israelita de Ensino e Pesquisa, São Paulo, Brazil. · Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Pathology, Patras General Hospital, Greece. · Department of Medical Sciences, University of Turin, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 26832993
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX · David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ · Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels · Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium · Hope S. Rugo, University of California, San Francisco · Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA · Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada · Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain · Thomas Bachelot, Centre Léon Bérard, Lyon, France · Shinzaburo Noguchi, Osaka University Medical School · Norikazu Masuda, Osaka National Hospital, Osaka, Japan · Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL · Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ · Shaker Dakhil, Cancer Center of Kansas, Wichita, KS · Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA · and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
2015
  • SOLTI Breast Cancer Research Group, Barcelona, Spain. · Medical Oncology, Arnau de Vilanova Hospital, Valencia, Spain. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Medical Oncology, University Clinic Hospital, Valencia, Spain. · Universitary Hospital of Besançon, Besançon, France. · Gustave Roussy Institute, Villejuif, France. · Medical Oncology, Arnau de Vilanova Hospital, Lleida, Spain. · Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Medical Oncology, Sant Joan de Reus Hospital, Reus, Spain. · Institut Bergonié, University of Bordeaux, INSERM U916, Bordeaux, France. · Medical Oncology, Virgen del Rocío Hospital, Sevilla, Spain. · Medical Oncology, 12 de Octubre Hospital, Madrid, Spain. · Institut Claudius Regaud, Toulouse, France. · Medical Oncology, Cáceres Hospital, Cáceres, Spain. · Medical Oncology, Valencia Oncology Institute, Valencia, Spain. · Medical Oncology, Jaen Hospital, Jaen, Spain. · Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of OB&GYN, Breast Center, University of Munich, Munich, Germany. · Sanofi Oncology Division, Cambridge, MA, USA. · Pathology Department, Jean Perrin Center, Clermont-Ferrand, France. · EA 4677 ERTICA University of Auvergne, Clermont-Ferrand, France. · Breast Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 26536871
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain · Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science Scotland, Kincraig, UK. · BrEAST Data Centre, Jules Bordet Institute, Brussels, Belgium. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · GlaxoSmithKline, Collegeville, USA. · University Hospital Kiel, Kiel, Germany. · Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York Breast Medicine Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25851628
  • Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands · Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology · Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain · Holger Eidtmann, University Hospital Kiel, Kiel · Nadia Harbeck, University of Munich, Munich, Germany · Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom · Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles · Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium · Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Catherine Ellis, GlaxoSmithKline, Collegeville, PA · and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25559818
  • All authors: Memorial Sloan Kettering Cancer Center, New York, NY. · All authors: Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 25547504
  • Vall d'Hebron University Hospital, Barcelona, Spain. · Merck & Co., Inc., Whitehouse Station, New Jersey. · Sarah Cannon Research Institute, Nashville, Tennessee. · Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain. · The Cancer Institute of New Jersey, New Brunswick, New Jersey. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Pubmed 25320355
  • Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, Urbana, IL 61801, USA. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic Barcelona, C/Rosselló 149-153, Barcelona 08035, Spain. · Massachusetts General Hospital Cancer Center and Harvard Medical School, 425 13th Street, Charlestown, MA 02129, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. Universitat Autònoma de Barcelona, Plaza Cívica, Campus UAB, 08193 Bellaterra, Spain. · Experimental Therapeutics Group, VHIO, Barcelona 08035, Spain. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Weill Cornell Medical College, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 25877889
  • CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Veterinary Medicine, Vienna, Austria. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. · CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria · Pubmed 25699542
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
  • Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, Massachusetts 02114, USA. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · 1] Department of Genetics, Washington University School of Medicine, 4566 Scott Avenue, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [3] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA. · 1] Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [2] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA [3] Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA. · 1] Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA. · 1] Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Division of Genitourinary Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · 1] Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Howard Hughes Medical Institute, Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · Novartis Pharma AG, Forum 1, Novartis Campus, CH-4056 Basel, Switzerland. · Oncology Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA. · 1] Department of Genetics, Washington University School of Medicine, 4566 Scott Avenue, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [3] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA [4] Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA. · 1] Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · Pubmed 25409150
  • Memorial Sloan Kettering Cancer Center, New York, NY · Roche Products, Welwyn Garden City, United Kingdom. · F. Hoffmann-La Roche, Basel, Switzerland. · Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC. · Pubmed 25870094
2014
  • US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: · US Food and Drug Administration, Silver Spring, MD, USA. · HELIOS Klinikum, Berlin, Germany. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA. · Institut Bergonié INSERM U916 and Université Bordeaux Segalen, Bordeaux, France. · Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, UK. · San Raffaele Scientific Institute, Milan, Italy. · Fondazione Michelangelo, Milan, Italy. · Medstar Washington Hospital Center, Washington, DC, USA. · EORTC Headquarters, Brussels, Belgium. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · St Gertrauden Hospital, Berlin, Germany. · MD Anderson Cancer Center Orlando, Orlando, FL, USA. · KarolinskaInstitutet and University Hospital, Stockholm, Sweden. · NN Petrov Research Institute of Oncology, St Petersburg, Russia. · University Women's Hospital, Kiel, Germany. · Jules Bordet Institute, Brussels, Belgium. · Frauenklinik des Universitätsklinikums, Erlangen, Germany. · Universitäts Frauenklinik, Rostock, Germany. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Hospital of the Ludwig Maximilian University of Munich, Munich, Germany. · Pubmed 24529560
  • José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Javier Cortés, Vall d'Hebron University Hospital, Barcelona, Spain · Seock-Ah Im, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea · Emma Clark and Graham Ross, Roche Products, Welwyn Garden City, United Kingdom · Astrid Kiermaier, F. Hoffmann-La Roche, Basel, Switzerland · and Sandra M. Swain, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC. · Pubmed 25332247
  • Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona · Jose A. Garcia-Saenz, Hospital Clinico San Carlos · Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain · Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China · Wael Harb, Horizon Medical Group, Lafayette, IN · Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL · Timothy Pluard, Washington University School of Medicine, St Louis, MO · Corinne Kiger, Pfizer Global Research and Development, Paris · Caroline Germa, Novartis Pharma, Rueil-Malmaison, France · Kongming Wang, Pfizer, Pearl River · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Pubmed 25287822
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. Electronic address: · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Istituto Nazionale del Tumori, Milan, Italy; SOLTI Breast Cancer Research Group, Spain. · GlaxoSmithKline, Collegeville, PA, USA. · Clinic for Gynaecology, Gynaecologic Oncology and Obstetrics and Breast Cancer Centre, HELIOS Klinikum Berlin, Buch, Germany. · Sana Klinikum Offenbach, Offenbach, Germany. · National Institute of Oncology, Budapest, Hungary. · Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, NSW, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · PUC-RS School of Medicine, Porto Alegre, Brazil. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. · Asian Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Kliniken Essen-Mitte, Essen, Germany. · National Taiwan University Hospital, Taipei, Taiwan. · Clinique St-Elisabeth, Namur, Belgium. · Mackay Memorial Hospital, Taipei, Taiwan. · Kashirskoye Shosse, Moscow, Russia. · Cancer Institute "Prof Dr Ion Chiricuta", Cluj-Napoca, Romania. · Department of Medical Oncology, University of Pretoria, Pretoria, South Africa. · Odessa Oncology Centre, Odessa, Ukraine. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Frontier Science and Technology Research Foundation, Boston, MA, USA. · University Hospital Kiel, Kiel, Germany. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25130998
  • Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet · Evandro de Azambuja, Breast European Adjuvant Study Team · Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie · David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh · Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research · Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom · Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands · Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA · Jutta Steinseifer, F. Hoffmann-La Roche, Basel · Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland · Michael Untch, HELIOS Klinikum Berlin, Buch · Christian Jackisch, Klinikum Offenbach, Offenbach, Germany · Luca Gianni, San Raffaele Institute, Milan, Italy · Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia · and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD. · Pubmed 24912899
  • University Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain · Beth Israel Deaconess Medical Center, Boston. · Massachusetts General Hospital, Boston. · University Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · AstraZeneca, Wilmington, USA. · AstraZeneca, Macclesfield, UK. · Dana-Farber Cancer Institute, Boston. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 24827126
  • Washington Cancer Institute, MedStar Washington Hospital Center, Washington · Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, USA. · Mount Vernon Cancer Centre, Middlesex, UK. · Division of Hematology and Medical Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Genentech, Inc., South San Francisco, USA. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 24685829
  • San Raffaele Hospital, Milan, Italy. Electronic address: · Interdisziplinäres Onkologisches Zentrum München, Munich, Germany. · NN Petrov Research Institute of Oncology, St Petersburg, Russia. · Hospital Clínico Universitario de Valencia-INCLIVA Health Research Institute, University of Valencia, Valencia, Spain. · NN Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia. · San Raffaele Hospital, Milan, Italy. · IRCCS Istituto Nazionale Tumori, Milan, Italy. · Vall d'Hebron University Hospital, Barcelona, Spain. · Central Clinical Hospital NA Semashko, Moscow, Russia. · Instituto Valenciano de Oncologia, Valencia, Spain. · Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain. · Hospital de la Santa Creu i Sant Pau, Department of Medical Oncology, Barcelona, Spain. · Department of Oncology, University Hospital of Udine, Udine, Italy. · Fondazione Michelangelo, Milan, Italy. · F Hoffmann-La Roche, Basel, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 24657003
  • Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 24401928
  • Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy; Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy. · Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy. · Clinical Research, Monogram Biosciences, Inc., 345 Oyster Point Blvd., South San Francisco, CA, USA. · Laboratory of Cell Therapy, Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Candiolo, Italy. · A.O. Città della Salute e della Scienza di Torino - sede Molinette, C.so Bramante 88/90, 10126 Torino, Italy. · Department of Biological Sciences and Human Oncology, Universita di Torino, Str. Provinciale 142, 10060 Candiolo, Italy. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Electronic address: · Pubmed 24075779
  • *Authors contributed equally to this work. · *Authors contributed equally to this work.Affiliations of authors: Preclinical Research (JLPP, BM, ME, RV, MZF, KP, VS, AP, JA) and Clinical Research Programs (PN, JC, ITR), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain (VP); Human Oncology and Pathogenesis Program (HOPP) and Memorial Sloan Kettering Cancer Center, New York, NY (MS, JB); Instituto de Biología Molecular y Celular del Cáncer, Campus Miguel de Unamuno, Salamanca, Spain (AP); Lineberger Comprehensive Cancer Center, Chapel Hill, NC (CMP); Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (JA). · Pubmed 25253614
  • : Breast Cancer Unit (AP, BA, MV, JC), Department of Medical Oncology (AP, BA, MV, JC, JT), and Translational Genomics Group (AP, MV), Vall d'Hebron Institute of Oncology Barcelona, Spain · Lineberger Comprehensive Cancer Center (LAC, JSP, CMP), Department of Genetics (CMP), and Department of Pathology and Laboratory Medicine (CMP), University of North Carolina, Chapel Hill, NC · Memorial Sloan-Kettering Cancer Center, New York (JB). · Pubmed 25139534
  • Genus Oncology, Boston, MA, USA. · Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 23912457
2013
  • Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 23876062
  • Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 23733761
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.) · Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter) · the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels · Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland · the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.) · the National Institute of Oncology, Budapest, Hungary (I.L.) · Centre François Baclesse, Caen, France (C.L.) · the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.) · Instituto Nacional de Câncer, Rio de Janeiro (J. Bines) · Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.) · and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
  • Oncology Department of the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY, USA. · Weill Cornell Medical College, New York, NY USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Pubmed 27748766
2016
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
2014
  • Washington Cancer Institute, MedStar Washington Hospital Center, Washington, D.C., USA; Division of Hematology and Medical Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Division of Hematology and Medical Oncology, Department of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Veterans Memorial Medical Center, Cancer Research Center, Quezon City, Philippines; Mount Vernon Cancer Centre, Middlesex, United Kingdom; Roche Products Ltd., Welwyn Garden City, United Kingdom; Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, New York, USA · Washington Cancer Institute, MedStar Washington Hospital Center, Washington, D.C., USA; Division of Hematology and Medical Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Division of Hematology and Medical Oncology, Department of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Veterans Memorial Medical Center, Cancer Research Center, Quezon City, Philippines; Mount Vernon Cancer Centre, Middlesex, United Kingdom; Roche Products Ltd., Welwyn Garden City, United Kingdom; Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, New York, USA. · Pubmed 24869931
  • Authors' Affiliations: Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain · Catalan Institute of Oncology, Barcelona, Spain · Sarah Cannon Research Institute, Nashville, Tennessee · Novartis Pharmaceuticals, East Hanover, NJ · Novartis Pharmaceuticals, Florham Park, New Jersy · C.H.U. Sart-Tilman, Liege · Oncologisch Centrum AZ-St. Augustinus Oncology, Antwerp, Belgium · Novartis Pharma AG, Basel, Switzerland · Novartis Oncology, Paris, France · Memorial Sloan-Kettering Cancer Centre, New York, New York · Highlands Oncology Group, Fayetteville, Arkansas · and Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. · Pubmed 24470511
  • Authors' Affiliations: Translational Genomics Group, Vall d'Hebron Institute of Oncology; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona; Hospital Clinico Universitario, Valencia, Spain; Oncologia Medica, San Raffaele Cancer Centre, Milan, Italy; Roche, Pharma Research and Early Development, Penzberg; Frauenklinik vom Roten Kreuz, Munich, Germany; University of North Carolina, Chapel Hill, North Carolina; NN Petrov Research Institute of Oncology, St Petersburg, Russian Federation; NN Blokhin Russian Cancer Centre; Central Clinical Hospital named after N A Semashko, Moscow, Russia; and Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24443618
2013
  • Authors' Affiliations: Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; and Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24298066
  • aVall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain bMedStar Washington Hospital Center, Washington Cancer Institute, Washington, District of Columbia cMid Ohio Oncology/Hematology Inc., The Mark H. Zangmeister Center, Columbus, Ohio dGenentech, South San Francisco, California eMemorial Sloan-Kettering Cancer Center, New York, New York, USA fRiga East University Hospital Oncology Center, Riga, Latvia gDaugavpils Reǵionālā Slimnīca, Daugavpils, Latvia hGesundheitszentrum Fricktal, Spital Rheinfelden & Laufenburg, Rheinfelden, Switzerland iNational Hospital Organization Osaka National Hospital, Osaka-City, Osaka, Japan jRoche Products Limited, Welwyn Garden City, UK kPharsight, Montreal, Quebec, Canada. · Pubmed 23969513
  • Memorial Sloan-Kettering Cancer Center/Weill Cornell Medical College, 300 East 66th Street, New York, NY 10065, USA. · Pubmed 23580070
  • Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York, USA. · Pubmed 24185512
  • Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 23903756
2011
  • Program in Molecular Pharmacology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 21215704
Probable:    Cornell University      
2017
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · AstraZeneca, iMED Oncology, Cambridge, UK. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · AstraZeneca, Discovery Sciences, IMED Biotech Unit, Cambridge, UK. · AstraZeneca, iMED Oncology, Waltham, Massachusetts. · Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois. · Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois. · Weill Cornell Medical College, New York, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27986707
2015
  • Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, Urbana, IL 61801, USA. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic Barcelona, C/Rosselló 149-153, Barcelona 08035, Spain. · Massachusetts General Hospital Cancer Center and Harvard Medical School, 425 13th Street, Charlestown, MA 02129, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. Universitat Autònoma de Barcelona, Plaza Cívica, Campus UAB, 08193 Bellaterra, Spain. · Experimental Therapeutics Group, VHIO, Barcelona 08035, Spain. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Weill Cornell Medical College, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 25877889
2017
  • Oncology Department of the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY, USA. · Weill Cornell Medical College, New York, NY USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Pubmed 27748766
2013
  • Memorial Sloan-Kettering Cancer Center/Weill Cornell Medical College, 300 East 66th Street, New York, NY 10065, USA. · Pubmed 23580070
Probable:    NewYork-Presbyterian Hospitals      
2017
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · AstraZeneca, iMED Oncology, Cambridge, UK. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · AstraZeneca, Discovery Sciences, IMED Biotech Unit, Cambridge, UK. · AstraZeneca, iMED Oncology, Waltham, Massachusetts. · Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois. · Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois. · Weill Cornell Medical College, New York, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27986707
2015
  • Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, Urbana, IL 61801, USA. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic Barcelona, C/Rosselló 149-153, Barcelona 08035, Spain. · Massachusetts General Hospital Cancer Center and Harvard Medical School, 425 13th Street, Charlestown, MA 02129, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. Universitat Autònoma de Barcelona, Plaza Cívica, Campus UAB, 08193 Bellaterra, Spain. · Experimental Therapeutics Group, VHIO, Barcelona 08035, Spain. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Weill Cornell Medical College, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 25877889
2017
  • Oncology Department of the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY, USA. · Weill Cornell Medical College, New York, NY USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Pubmed 27748766
2013
  • Memorial Sloan-Kettering Cancer Center/Weill Cornell Medical College, 300 East 66th Street, New York, NY 10065, USA. · Pubmed 23580070
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 154 total) written by Jose Baselga about Breast Neoplasms:

  • The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO. 2018
  • Advances in the management of HER2-positive early breast cancer. 2017
  • Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE). 2017
  • A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer. 2017
  • RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer. 2017
  • Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. 2017
  • A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer. 2017
  • Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer. 2017
  • Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial. 2017
  • MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR 2017
Show List of Full Article Records
Google Searches

Learn more about Jose Baselga using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Memorial Sloan-Kettering Cancer Center
Cornell University
NewYork-Presbyterian Hospitals
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Memorial Sloan-Kettering Cancer Center
2018
  • Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. Electronic address: · Frontier Science (Scotland) Ltd., Kincraig, UK. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. · IRCCS A.O.U. S.Martino-IST, Genoa, Italy. · European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast International Group (BIG), Brussels, Belgium. · Instituto de Oncologia de Rosário, Rosário, Argentina. · Clinica de Oncologia, Porto Alegre, Brazil. · Queen Elizabeth Hospital, Hong Kong, China. · Istituto Europeo di Oncologia, Milan, Italy. · Ospedale di Trento, Trento, Italy. · Oslo University Hospital, Oslo, Norway. · The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom. · Ulm University Hospital, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29227816
2017
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States. · University of Sheffield, Weston Park Hospital, Sheffield, United Kingdom. Electronic address: · Ramón y Cajal University Hospital, Madrid, Spain. · University of Ulm, Ulm, Germany. · Pubmed 29042085
  • German Breast Group, Neu-Isenburg, Germany; Sana-Klinikum Offenbach, Germany. Electronic address: · SOLTI Breast Cancer Research Group, Barcelona, Spain. · German Breast Group, Neu-Isenburg, Germany. · Breast International Group, Brussels, Belgium. · Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Villejuif, France; CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Institute of Pathology, Charité University Hospital, Berlin, Germany. · Luisenkrankenhaus Düsseldorf, Germany. · Hospital Clinico Universitario de Valencia, Spain. · Helios Klinikum Berlin-Buch, Department of Obstetrics and Gynaecology, Berlin, Germany. · Department of Haematology-Oncology, National University Cancer Institute, Singapore. · Novartis Pharma SAS, Rueil Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Kliniken Essen-Mitte, Essen, Germany. · Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, Austria; Comprehensive Cancer Center Vienna, Austria. · Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · University Breast Centre of Franconia, OBGYN Department, University Hospital Erlangen, CCC Erlangen-EMN, Germany. · Breast International Group, Brussels, Belgium; Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · SOLTI Breast Cancer Research Group, Barcelona, Spain; Memorial Sloan-Kettering Cancer Center, New York, USA. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Australian New Zealand Breast Cancer Trials Group (ANZBCTG), Newcastle, Australia. Electronic address: · Pubmed 28923573
  • Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · Seoul National University College of Medicine, Seoul, Republic of Korea. · National Taiwan University Hospital, Taipei, Taiwan. · Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Moores Cancer Center, University of California at San Diego, La Jolla, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Huntsman Cancer Institute, Salt Lake City, UT, USA. · Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. · University of Chicago, Chicago, IL, USA. · City of Hope, Department of Medical Oncology and Therapeutics Research, Duarte, CA, USA. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pfizer Inc., New York, NY, USA. · Novartis Institutes for BioMedical Research, Cambridge, MA, USA. · Pubmed 28899363
  • Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: · S. Orsola Malpighi Hospital, Bologna, Italy. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Hospital Clínico Universitario de Valencia, Valencia, Spain. · Saitama Cancer Center, Saitama, Japan. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · Curtin Health Innovation Research Institute, Curtin University, Perth, Australia. · University of Pécs, Pécs, Hungary. · Karolinska Institutet and University Hospital, Stockholm, Sweden. · Hospital Sírio Libanês, São Paulo, Brazil. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Northwestern University Feinberg School of Medicine, Chicago, IL. · Memorial Sloan Kettering Cancer Center, New York, NY. · The Medical Oncology Center of Rosebank and Linksfield Park Hospital, Johannesburg, South Africa. · Institut Claudius Régaud, Toulouse, France. · Bayer HealthCare Pharmaceuticals, Whippany, NJ. · The West Clinic, Memphis, TN. · Pubmed 28830796
  • Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: · Division of Medical Oncology, National Cancer Centre, Singapore, Singapore. · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Breast Disease Center, Hospital Saint Louis, Paris, France. · Northwest Medical Specialties and Division of Oncology, University of Washington, Washington, WA, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Massachusetts General Hospital, Boston, MA, USA. · Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Genentech Inc, South San Francisco, CA, USA. · Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28800861
  • UCSF Helen, Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Centre Léon Bérard, Lyon, France. · National Cancer Center, Goyang, Republic of Korea. · H. de Lleida Arnau de Vilanova, Lerida, Spain. · Institut de Cancérologie de l'Ouest, St Herblain-Nantes, France. · University Hospital of Parma, Parma, Italy. · Instituto Português de Oncologia Francisco Gentil, Porto, Portugal. · Korea University Medical Center, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Merck& Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · Alexion Pharmaceuticals, New Haven, CT, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28681171
  • Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain. · Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada. · Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Department of Oncology, Ospedale di Macerata, Macerata, Italy. · Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. · Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium. · Novartis Pharma SAS, Paris, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Syros Pharmaceuticals, Watertown, MA, USA. · Novartis Pharma AG, Basel, Switzerland. · Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. · Pubmed 28576675
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of California San Francisco Comprehensive Cancer Center, San Francisco, California. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Institut Curie, Paris, France. · Texas Oncology, Austin, Texas. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center, New York, New York. · Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, Tennessee. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28533223
  • Department of Medical Oncology, Institut Curie, Paris, France. Electronic address: · Mount Vernon Cancer Centre, Northwood, UK. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Stanford Cancer Institute, Palo Alto, CA, USA. · Medical Office Hematology, Aschaffenburg, Germany. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Duke University Medical Center, Durham, NC, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Genentech Inc, South San Francisco, CA, USA. · San Raffaele Hospital, Milan, Italy. · Pubmed 28526536
  • Memorial Sloan Kettering Cancer Center, New York, NY, USA. · H. de Lleida Arnau de Vilanova, Lérida, Spain. · Institut Jules Bordet, Brussels, Belgium. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Ramon y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Massachusetts General Hospital, Boston, MA, USA. · Mayo Clinic, Rochester, MN, USA. · University of Minnesota Masonic Clinical Cancer Center, Minneapolis, MN, USA. · Hospital 12 de Octubre, Madrid, Spain. · Clinique Sainte Elisabeth, Namur, Belgium. · Merck & Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St., San Francisco, CA, USA. · Pubmed 28324268
  • University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. Electronic address: · Department of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · Frontier Science Scotland Ltd, Kincraig, Kingussie, UK. · European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. · Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Helios Klinikum Berlin Buch, Multidisciplinary Breast Cancer Center, Berlin, Germany. · Breast Unit, Royal Marsden Hospital, and The Institute of Cancer Research, London, UK. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Avera Cancer Institute Center for Precision Oncology, Sioux Falls, SD, USA. · Deakin University, Waurn Ponds, VIC, Australia. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Pubmed 28215665
  • Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA. · National Center for Tumor Diseases, University Hospital Heidelberg, Germany. · Department of Gynecology and Obstetrics, University Hospital Heidelberg, Heidelberg, Germany. · Department of Medical Oncology, San Raffaele Hospital, Milan, Italy. · Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, MA, USA. · BioOncology, Genentech, Inc., South San Francisco, CA, USA. · Clinical Development, Roche Products Ltd, Welwyn Garden City, UK. · Biostatistics, Genentech, Inc., South San Francisco, CA, USA. · Ramon y Cajal University Hospital, Madrid, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 28057664
  • Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Radiology and Radiological Science, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Genentech, Inc., South San Francisco, California. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28011460
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
  • Breast Cancer Program, Istituto Europeo di Oncologia, Milano, Italy. · Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Klinik St. Anna, Luzern, Switzerland. · German Breast Group, Neu-Isenburg, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Medical Oncology, Institut Jules Bordet, UniversitÕ Libre de Bruxelles, Brussels, Belgium. · Tumor and Breast Center ZeTuP, St. Gallen. · Breast Center, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Institut de Cancérologie Gustave Roussy, Villejuif, France. · Memorial Sloan Kettering Cancer Center, New York, USA. · Karolinska Institute and University Hospital, Stockholm, Sweden. · University of Bordeaux, Bordeaux, France. · Universitäts-Frauenklinik Tübingen, Tübingen, Germany. · Champalimaud Cancer Centre, Lisbon, Portugal. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany. · Azienda Usl Toscana Centro, Prato, Italy. · Rigshospitalet, Copenhagen, Denmark. · Peter McCallum Cancer Centre, Melbourne, Australia. · Marmara University School of Medicine, Istanbul, Turkey. · University of Toronto, Mount Sinai Hospital, Toronto, Canada. · University of Munich, München, Germany. · Comprehensive Cancer Center, University of Michigan, Ann-Arbor, USA. · National Taiwan University Hospital, Taipei, Taiwan. · University of Ulm, Ulm, Germany. · The National Cancer Institute, Cairo University, Cairo, Egypt. · Medical University of Gdansk, Gdansk, Poland. · Hospital Affiliated to Military Medical Science, Beijing, China. · Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden. · Baylor College of Medicine, Houston, USA. · Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Canada. · National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria. · N.N. Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Fudan University Cancer Hospital, Shanghai, China. · The Royal Marsden, Sutton, Surrey, UK. · Graduate School of Medicine Kyoto University, Sakyo-ku, Kyoto City, Japan. · Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK. · University of Milan, Milan. · Istituto Europeo di Oncologia, Milan, Italy. · Hamamatsu Oncology Center, Hamamatsu, Japan. · McMaster University, Hamilton, Canada. · National Cancer Center, Chaoyang District, Beijing, China. · Pubmed 28838210
  • The Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02124, USA. · Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts 02129, USA. · Division of Health Sciences and Technology, MIT, Cambridge, Massachusetts 02139, USA. · Instituto de Enfermedades de la Mama FUCAM, A.C., Mexico City 04980, Mexico. · Princess Margaret Cancer Centre, University Health Network and the Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada. · Harvard Medical School, Boston, Massachusetts 02115, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico. · Massachusetts General Hospital, Department of Pathology, Boston, Massachusetts 02114, USA. · Pubmed 28658208
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Prometheus Laboratories, San Diego, California. · Foundation Medicine, Cambridge, Massachusetts. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Department of Gynecology, University of Ulm, Ulm, Germany. · Novartis Pharmaceuticals, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Pubmed 28381415
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Computational Biology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 460, New York, NY 10065, USA. · Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, 1450 3rd Street, San Francisco, CA 94158, USA. · Microchemistry and Proteomics Core Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 28336670
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Oncology Precision Medicine, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA. · Global Medical Affairs, Novartis Pharma AG, Basel CH-4002, Switzerland. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 28183140
  • Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science, Inverness, Scotland. · Breast Center, Department of Obstetrics and Gynecology, University of Munich, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Hospital Moinhos de Vento, Porto Alegre, Brazil. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · The Christie/NIHR Clinical Research Facility, Manchester, UK. · Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · Novartis, Cambridge. · Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, USA. · Pubmed 28177460
  • Memorial Sloan Kettering Cancer Center, New York, New York, USA · Department of Surgery, Beth Israel Deaconess Medical Center, Harvard School of Medicine, Boston, Massachusetts, USA. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Clínica de Oncologia (CLION), Clínica de Assistência à Mulher (CAM) Group, Salvador, Bahia, Brazil. · Pubmed 28167568
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · AstraZeneca, iMED Oncology, Cambridge, UK. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · AstraZeneca, Discovery Sciences, IMED Biotech Unit, Cambridge, UK. · AstraZeneca, iMED Oncology, Waltham, Massachusetts. · Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois. · Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois. · Weill Cornell Medical College, New York, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27986707
2016
  • Memorial Sloan Kettering Cancer Center (MSKCC), Human Oncology and Pathogenesis Program (HOPP), NY, USA. · Unit of Investigative Clinical Oncology, Institute for Cancer Research and Treatment, Candiolo, Italy. · Bioinformatics Institute (A*STAR), #07-01 Matrix, 30 Biopolis Street #07-01, 138671, Singapore. · Medical Oncology, Ospedale Civile di Saluzzo, Saluzzo, Italy. · Bioinformatics Institute (A*STAR), #07-01 Matrix, 30 Biopolis Street #07-01, 138671, Singapore; Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, 117543, Singapore; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore. · Memorial Sloan Kettering Cancer Center (MSKCC), Human Oncology and Pathogenesis Program (HOPP), NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Memorial Sloan Kettering Cancer Center (MSKCC), Human Oncology and Pathogenesis Program (HOPP), NY, USA. Electronic address: · Pubmed 26645663
  • Breast Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY, 10065, USA. · Breast Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY, 10065, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA. · NewYork-Presbyterian/Lawrence Hospital, New York, USA. · CLION, Salvador, Brazil. · Pubmed 27306421
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Genentech, Inc., South San Francisco, California. · Sunnybrook Odette Cancer Centre, Toronto, Canada. · National Cancer Center, Goyang, Korea. · Breast Center, Kantonsspital St. Gallen, St. Gallen, Switzerland. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · Stanford Cancer Institute, Palo Alto, California. · Pubmed 26920887
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26454612
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain; Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Universitat Autonoma de Barcelona, 08035 Barcelona, Spain. · Department of Structural Immunology, Institute of Innate Immunity, University of Bonn, 53127 Bonn, Germany; Group Physical Biochemistry, Center of Advanced European Studies and Research, 53175 Bonn, Germany. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Radiation Oncology and Center for DNA Damage and Repair, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital and Harvard Medical School, Boston, MA 02215, USA. · Developmental Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent's Health Network, Darlinghurst, NSW 2010, Australia. · Department of Radiation Oncology and Center for DNA Damage and Repair, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; Department of Medicine, Harvard Medical School, Boston, MA 02114, USA. · Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Universitat Autonoma de Barcelona, 08035 Barcelona, Spain. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent's Health Network, Darlinghurst, NSW 2010, Australia. Electronic address: · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: · Pubmed 27880910
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · DNA Damage Response Biology Area, Oncology IMED, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK. · OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. · Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY 10065, USA. · Translational Research Department, Institut Curie, 26 rue d'Ulm, Paris 75005, France. · Huntsman Cancer Institute, Salt Lake City, UT 84112, USA. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 27641504
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · The Broad Institute of MIT and Harvard, Cambridge, MA. · Division of Hematology Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston MA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, NewYork, NY. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine, Brigham and Women's Hospital, Boston MA. · Pubmed 27604488
  • CIC bioGUNE, Bizkaia Technology Park, Bulding 801a, 48160 Derio, Spain. · Oncology Programme, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · Oncology Area, Biodonostia Institute, 20014 San Sebastian, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. · ERTICa Research Group, University of Auvergne EA4677, Clermont-Ferrand, France. · Biodiagnostics Laboratory OncoGenAuvergne, Pathology Unit, Jean Perrin Comprehensive Cancer Center, 63000 Clermont-Ferrand, France. · Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 13288 Marseille, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). · IKERBASQUE, Basque foundation for science, 48013 Bilbao, Spain. · Experimental Therapeutics Group, Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Weill Cornell Medicine, New York 10021, USA. · Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), 48949 Leioa, Spain. · Pubmed 27553708
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · University of Texas MD Anderson Cancer Center, Houston. · Pubmed 27532364
  • MRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences University of Dundee, Dundee, UK · MRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences University of Dundee, Dundee, UK. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Oncology iMED, AstraZeneca CRUK Cambridge Institute, Cambridge, UK. · Department of Biochemistry, Institute of Integrative Biology University of Liverpool, Liverpool, UK. · Pubmed 27481935
  • German Breast Group, Neu-Isenburg, Germany · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Surgery, Oncology and Gastroenterology, University of Padua, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · German Breast Group, Neu-Isenburg, Germany. · Frontier Science Scotland, Kincraig, UK. · Department of Medical Oncology, University of Verona, Verona, Italy. · Institute of Pathology, Charité Universitätsmedizin Berlin, and German Cancer Consortium (DKTK), Berlin. · Department of Obstetrics and Gynecology, University Hospital Kiel, Kiel, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussel, Belgium. · Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Obstetrics and Gynecology, Helios-Klinikum, Berlin-Buch, Germany. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 27177864
  • The Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Weill Cornell Medicine, Cornell University, New York, New York. · Medical Oncology, Hospital Vall d'Hebron, Spain. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · The Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom. Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom. · The Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom. Breast Unit, Royal Marsden Hospital, London, United Kingdom. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 27020857
  • Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, New York, New York. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26957555
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Pathology, Hospital Israelita Albert Einstein, Instituto Israelita de Ensino e Pesquisa, São Paulo, Brazil. · Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Pathology, Patras General Hospital, Greece. · Department of Medical Sciences, University of Turin, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 26832993
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX · David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ · Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels · Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium · Hope S. Rugo, University of California, San Francisco · Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA · Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada · Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain · Thomas Bachelot, Centre Léon Bérard, Lyon, France · Shinzaburo Noguchi, Osaka University Medical School · Norikazu Masuda, Osaka National Hospital, Osaka, Japan · Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL · Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ · Shaker Dakhil, Cancer Center of Kansas, Wichita, KS · Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA · and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
2015
  • SOLTI Breast Cancer Research Group, Barcelona, Spain. · Medical Oncology, Arnau de Vilanova Hospital, Valencia, Spain. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Medical Oncology, University Clinic Hospital, Valencia, Spain. · Universitary Hospital of Besançon, Besançon, France. · Gustave Roussy Institute, Villejuif, France. · Medical Oncology, Arnau de Vilanova Hospital, Lleida, Spain. · Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Medical Oncology, Sant Joan de Reus Hospital, Reus, Spain. · Institut Bergonié, University of Bordeaux, INSERM U916, Bordeaux, France. · Medical Oncology, Virgen del Rocío Hospital, Sevilla, Spain. · Medical Oncology, 12 de Octubre Hospital, Madrid, Spain. · Institut Claudius Regaud, Toulouse, France. · Medical Oncology, Cáceres Hospital, Cáceres, Spain. · Medical Oncology, Valencia Oncology Institute, Valencia, Spain. · Medical Oncology, Jaen Hospital, Jaen, Spain. · Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of OB&GYN, Breast Center, University of Munich, Munich, Germany. · Sanofi Oncology Division, Cambridge, MA, USA. · Pathology Department, Jean Perrin Center, Clermont-Ferrand, France. · EA 4677 ERTICA University of Auvergne, Clermont-Ferrand, France. · Breast Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 26536871
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain · Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science Scotland, Kincraig, UK. · BrEAST Data Centre, Jules Bordet Institute, Brussels, Belgium. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · GlaxoSmithKline, Collegeville, USA. · University Hospital Kiel, Kiel, Germany. · Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York Breast Medicine Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25851628
  • Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands · Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology · Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain · Holger Eidtmann, University Hospital Kiel, Kiel · Nadia Harbeck, University of Munich, Munich, Germany · Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom · Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles · Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium · Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Catherine Ellis, GlaxoSmithKline, Collegeville, PA · and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25559818
  • All authors: Memorial Sloan Kettering Cancer Center, New York, NY. · All authors: Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 25547504
  • Vall d'Hebron University Hospital, Barcelona, Spain. · Merck & Co., Inc., Whitehouse Station, New Jersey. · Sarah Cannon Research Institute, Nashville, Tennessee. · Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain. · The Cancer Institute of New Jersey, New Brunswick, New Jersey. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Pubmed 25320355
  • Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, Urbana, IL 61801, USA. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic Barcelona, C/Rosselló 149-153, Barcelona 08035, Spain. · Massachusetts General Hospital Cancer Center and Harvard Medical School, 425 13th Street, Charlestown, MA 02129, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. Universitat Autònoma de Barcelona, Plaza Cívica, Campus UAB, 08193 Bellaterra, Spain. · Experimental Therapeutics Group, VHIO, Barcelona 08035, Spain. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Weill Cornell Medical College, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 25877889
  • CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Veterinary Medicine, Vienna, Austria. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. · CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria · Pubmed 25699542
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
  • Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, Massachusetts 02114, USA. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · 1] Department of Genetics, Washington University School of Medicine, 4566 Scott Avenue, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [3] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA. · 1] Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [2] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA [3] Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA. · 1] Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA. · 1] Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Division of Genitourinary Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · 1] Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Howard Hughes Medical Institute, Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · Novartis Pharma AG, Forum 1, Novartis Campus, CH-4056 Basel, Switzerland. · Oncology Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA. · 1] Department of Genetics, Washington University School of Medicine, 4566 Scott Avenue, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [3] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA [4] Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA. · 1] Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · Pubmed 25409150
  • Memorial Sloan Kettering Cancer Center, New York, NY · Roche Products, Welwyn Garden City, United Kingdom. · F. Hoffmann-La Roche, Basel, Switzerland. · Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC. · Pubmed 25870094
2014
  • US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: · US Food and Drug Administration, Silver Spring, MD, USA. · HELIOS Klinikum, Berlin, Germany. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA. · Institut Bergonié INSERM U916 and Université Bordeaux Segalen, Bordeaux, France. · Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, UK. · San Raffaele Scientific Institute, Milan, Italy. · Fondazione Michelangelo, Milan, Italy. · Medstar Washington Hospital Center, Washington, DC, USA. · EORTC Headquarters, Brussels, Belgium. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · St Gertrauden Hospital, Berlin, Germany. · MD Anderson Cancer Center Orlando, Orlando, FL, USA. · KarolinskaInstitutet and University Hospital, Stockholm, Sweden. · NN Petrov Research Institute of Oncology, St Petersburg, Russia. · University Women's Hospital, Kiel, Germany. · Jules Bordet Institute, Brussels, Belgium. · Frauenklinik des Universitätsklinikums, Erlangen, Germany. · Universitäts Frauenklinik, Rostock, Germany. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Hospital of the Ludwig Maximilian University of Munich, Munich, Germany. · Pubmed 24529560
  • José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Javier Cortés, Vall d'Hebron University Hospital, Barcelona, Spain · Seock-Ah Im, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea · Emma Clark and Graham Ross, Roche Products, Welwyn Garden City, United Kingdom · Astrid Kiermaier, F. Hoffmann-La Roche, Basel, Switzerland · and Sandra M. Swain, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC. · Pubmed 25332247
  • Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona · Jose A. Garcia-Saenz, Hospital Clinico San Carlos · Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain · Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China · Wael Harb, Horizon Medical Group, Lafayette, IN · Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL · Timothy Pluard, Washington University School of Medicine, St Louis, MO · Corinne Kiger, Pfizer Global Research and Development, Paris · Caroline Germa, Novartis Pharma, Rueil-Malmaison, France · Kongming Wang, Pfizer, Pearl River · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Pubmed 25287822
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. Electronic address: · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Istituto Nazionale del Tumori, Milan, Italy; SOLTI Breast Cancer Research Group, Spain. · GlaxoSmithKline, Collegeville, PA, USA. · Clinic for Gynaecology, Gynaecologic Oncology and Obstetrics and Breast Cancer Centre, HELIOS Klinikum Berlin, Buch, Germany. · Sana Klinikum Offenbach, Offenbach, Germany. · National Institute of Oncology, Budapest, Hungary. · Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, NSW, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · PUC-RS School of Medicine, Porto Alegre, Brazil. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. · Asian Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Kliniken Essen-Mitte, Essen, Germany. · National Taiwan University Hospital, Taipei, Taiwan. · Clinique St-Elisabeth, Namur, Belgium. · Mackay Memorial Hospital, Taipei, Taiwan. · Kashirskoye Shosse, Moscow, Russia. · Cancer Institute "Prof Dr Ion Chiricuta", Cluj-Napoca, Romania. · Department of Medical Oncology, University of Pretoria, Pretoria, South Africa. · Odessa Oncology Centre, Odessa, Ukraine. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Frontier Science and Technology Research Foundation, Boston, MA, USA. · University Hospital Kiel, Kiel, Germany. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25130998
  • Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet · Evandro de Azambuja, Breast European Adjuvant Study Team · Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie · David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh · Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research · Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom · Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands · Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA · Jutta Steinseifer, F. Hoffmann-La Roche, Basel · Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland · Michael Untch, HELIOS Klinikum Berlin, Buch · Christian Jackisch, Klinikum Offenbach, Offenbach, Germany · Luca Gianni, San Raffaele Institute, Milan, Italy · Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia · and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD. · Pubmed 24912899
  • University Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain · Beth Israel Deaconess Medical Center, Boston. · Massachusetts General Hospital, Boston. · University Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · AstraZeneca, Wilmington, USA. · AstraZeneca, Macclesfield, UK. · Dana-Farber Cancer Institute, Boston. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 24827126
  • Washington Cancer Institute, MedStar Washington Hospital Center, Washington · Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, USA. · Mount Vernon Cancer Centre, Middlesex, UK. · Division of Hematology and Medical Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Genentech, Inc., South San Francisco, USA. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 24685829
  • San Raffaele Hospital, Milan, Italy. Electronic address: · Interdisziplinäres Onkologisches Zentrum München, Munich, Germany. · NN Petrov Research Institute of Oncology, St Petersburg, Russia. · Hospital Clínico Universitario de Valencia-INCLIVA Health Research Institute, University of Valencia, Valencia, Spain. · NN Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia. · San Raffaele Hospital, Milan, Italy. · IRCCS Istituto Nazionale Tumori, Milan, Italy. · Vall d'Hebron University Hospital, Barcelona, Spain. · Central Clinical Hospital NA Semashko, Moscow, Russia. · Instituto Valenciano de Oncologia, Valencia, Spain. · Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain. · Hospital de la Santa Creu i Sant Pau, Department of Medical Oncology, Barcelona, Spain. · Department of Oncology, University Hospital of Udine, Udine, Italy. · Fondazione Michelangelo, Milan, Italy. · F Hoffmann-La Roche, Basel, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 24657003
  • Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 24401928
  • Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy; Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy. · Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy. · Clinical Research, Monogram Biosciences, Inc., 345 Oyster Point Blvd., South San Francisco, CA, USA. · Laboratory of Cell Therapy, Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Candiolo, Italy. · A.O. Città della Salute e della Scienza di Torino - sede Molinette, C.so Bramante 88/90, 10126 Torino, Italy. · Department of Biological Sciences and Human Oncology, Universita di Torino, Str. Provinciale 142, 10060 Candiolo, Italy. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Electronic address: · Pubmed 24075779
  • *Authors contributed equally to this work. · *Authors contributed equally to this work.Affiliations of authors: Preclinical Research (JLPP, BM, ME, RV, MZF, KP, VS, AP, JA) and Clinical Research Programs (PN, JC, ITR), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain (VP); Human Oncology and Pathogenesis Program (HOPP) and Memorial Sloan Kettering Cancer Center, New York, NY (MS, JB); Instituto de Biología Molecular y Celular del Cáncer, Campus Miguel de Unamuno, Salamanca, Spain (AP); Lineberger Comprehensive Cancer Center, Chapel Hill, NC (CMP); Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (JA). · Pubmed 25253614
  • : Breast Cancer Unit (AP, BA, MV, JC), Department of Medical Oncology (AP, BA, MV, JC, JT), and Translational Genomics Group (AP, MV), Vall d'Hebron Institute of Oncology Barcelona, Spain · Lineberger Comprehensive Cancer Center (LAC, JSP, CMP), Department of Genetics (CMP), and Department of Pathology and Laboratory Medicine (CMP), University of North Carolina, Chapel Hill, NC · Memorial Sloan-Kettering Cancer Center, New York (JB). · Pubmed 25139534
  • Genus Oncology, Boston, MA, USA. · Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 23912457
2013
  • Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 23876062
  • Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 23733761
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.) · Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter) · the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels · Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland · the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.) · the National Institute of Oncology, Budapest, Hungary (I.L.) · Centre François Baclesse, Caen, France (C.L.) · the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.) · Instituto Nacional de Câncer, Rio de Janeiro (J. Bines) · Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.) · and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
  • Oncology Department of the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY, USA. · Weill Cornell Medical College, New York, NY USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Pubmed 27748766
2016
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
2014
  • Washington Cancer Institute, MedStar Washington Hospital Center, Washington, D.C., USA; Division of Hematology and Medical Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Division of Hematology and Medical Oncology, Department of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Veterans Memorial Medical Center, Cancer Research Center, Quezon City, Philippines; Mount Vernon Cancer Centre, Middlesex, United Kingdom; Roche Products Ltd., Welwyn Garden City, United Kingdom; Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, New York, USA · Washington Cancer Institute, MedStar Washington Hospital Center, Washington, D.C., USA; Division of Hematology and Medical Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Division of Hematology and Medical Oncology, Department of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Veterans Memorial Medical Center, Cancer Research Center, Quezon City, Philippines; Mount Vernon Cancer Centre, Middlesex, United Kingdom; Roche Products Ltd., Welwyn Garden City, United Kingdom; Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, New York, USA. · Pubmed 24869931
  • Authors' Affiliations: Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain · Catalan Institute of Oncology, Barcelona, Spain · Sarah Cannon Research Institute, Nashville, Tennessee · Novartis Pharmaceuticals, East Hanover, NJ · Novartis Pharmaceuticals, Florham Park, New Jersy · C.H.U. Sart-Tilman, Liege · Oncologisch Centrum AZ-St. Augustinus Oncology, Antwerp, Belgium · Novartis Pharma AG, Basel, Switzerland · Novartis Oncology, Paris, France · Memorial Sloan-Kettering Cancer Centre, New York, New York · Highlands Oncology Group, Fayetteville, Arkansas · and Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. · Pubmed 24470511
  • Authors' Affiliations: Translational Genomics Group, Vall d'Hebron Institute of Oncology; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona; Hospital Clinico Universitario, Valencia, Spain; Oncologia Medica, San Raffaele Cancer Centre, Milan, Italy; Roche, Pharma Research and Early Development, Penzberg; Frauenklinik vom Roten Kreuz, Munich, Germany; University of North Carolina, Chapel Hill, North Carolina; NN Petrov Research Institute of Oncology, St Petersburg, Russian Federation; NN Blokhin Russian Cancer Centre; Central Clinical Hospital named after N A Semashko, Moscow, Russia; and Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24443618
2013
  • Authors' Affiliations: Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; and Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24298066
  • aVall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain bMedStar Washington Hospital Center, Washington Cancer Institute, Washington, District of Columbia cMid Ohio Oncology/Hematology Inc., The Mark H. Zangmeister Center, Columbus, Ohio dGenentech, South San Francisco, California eMemorial Sloan-Kettering Cancer Center, New York, New York, USA fRiga East University Hospital Oncology Center, Riga, Latvia gDaugavpils Reǵionālā Slimnīca, Daugavpils, Latvia hGesundheitszentrum Fricktal, Spital Rheinfelden & Laufenburg, Rheinfelden, Switzerland iNational Hospital Organization Osaka National Hospital, Osaka-City, Osaka, Japan jRoche Products Limited, Welwyn Garden City, UK kPharsight, Montreal, Quebec, Canada. · Pubmed 23969513
  • Memorial Sloan-Kettering Cancer Center/Weill Cornell Medical College, 300 East 66th Street, New York, NY 10065, USA. · Pubmed 23580070
  • Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York, USA. · Pubmed 24185512
  • Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 23903756
2011
  • Program in Molecular Pharmacology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 21215704
Cornell University
2017
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · AstraZeneca, iMED Oncology, Cambridge, UK. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · AstraZeneca, Discovery Sciences, IMED Biotech Unit, Cambridge, UK. · AstraZeneca, iMED Oncology, Waltham, Massachusetts. · Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois. · Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois. · Weill Cornell Medical College, New York, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27986707
2015
  • Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, Urbana, IL 61801, USA. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic Barcelona, C/Rosselló 149-153, Barcelona 08035, Spain. · Massachusetts General Hospital Cancer Center and Harvard Medical School, 425 13th Street, Charlestown, MA 02129, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. Universitat Autònoma de Barcelona, Plaza Cívica, Campus UAB, 08193 Bellaterra, Spain. · Experimental Therapeutics Group, VHIO, Barcelona 08035, Spain. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Weill Cornell Medical College, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 25877889
2017
  • Oncology Department of the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY, USA. · Weill Cornell Medical College, New York, NY USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Pubmed 27748766
2013
  • Memorial Sloan-Kettering Cancer Center/Weill Cornell Medical College, 300 East 66th Street, New York, NY 10065, USA. · Pubmed 23580070
NewYork-Presbyterian Hospitals
2017
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · AstraZeneca, iMED Oncology, Cambridge, UK. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · AstraZeneca, Discovery Sciences, IMED Biotech Unit, Cambridge, UK. · AstraZeneca, iMED Oncology, Waltham, Massachusetts. · Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois. · Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois. · Weill Cornell Medical College, New York, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27986707
2015
  • Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, Urbana, IL 61801, USA. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic Barcelona, C/Rosselló 149-153, Barcelona 08035, Spain. · Massachusetts General Hospital Cancer Center and Harvard Medical School, 425 13th Street, Charlestown, MA 02129, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. Universitat Autònoma de Barcelona, Plaza Cívica, Campus UAB, 08193 Bellaterra, Spain. · Experimental Therapeutics Group, VHIO, Barcelona 08035, Spain. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Weill Cornell Medical College, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 25877889
2017
  • Oncology Department of the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY, USA. · Weill Cornell Medical College, New York, NY USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Pubmed 27748766
2013
  • Memorial Sloan-Kettering Cancer Center/Weill Cornell Medical College, 300 East 66th Street, New York, NY 10065, USA. · Pubmed 23580070
Harvard University
2015
  • Vall d'Hebron University Hospital, Barcelona, Spain. · Merck & Co., Inc., Whitehouse Station, New Jersey. · Sarah Cannon Research Institute, Nashville, Tennessee. · Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain. · The Cancer Institute of New Jersey, New Brunswick, New Jersey. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Pubmed 25320355
2013
  • Weill Cornell Medical College, New York, NY, USA. Electronic address: · Klinicka Bolnica Split, Split, Croatia. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · St. Luke's Medical Center, Quezon City, Philippines. · Wilshire Oncology, Pomona, CA, USA. · Montefiore Medical Center, Bronx, NY, USA. · MGH Cancer Center, Massachusetts General Hospital, Boston, MA, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 24472478
2012
  • Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Pubmed 22412143
  • Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA. · Pubmed 22257673
  • Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA. · Pubmed 22149876
  • Division of Hematology-Oncology, Massachusetts General Hospital, Boston, USA. · Pubmed 22621630
  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA 02114, USA. · Pubmed 22149875
2011
  • Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. · Pubmed 21278436
2010
  • Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Pubmed 20943641
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.) · Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter) · the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels · Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland · the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.) · the National Institute of Oncology, Budapest, Hungary (I.L.) · Centre François Baclesse, Caen, France (C.L.) · the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.) · Instituto Nacional de Câncer, Rio de Janeiro (J. Bines) · Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.) · and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2014
  • 1Massachusetts General Hospital Cancer Center and Harvard Medical School, 149 13th Street, Charlestown, MA 02129, USA. · Pubmed 24667376
2013
  • Authors' Affiliations: Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; and Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24298066
  • Division of Women's Cancers, Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey Building 1238, Boston, MA 02215, USA. · Pubmed 23359433
  • Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, MA, USA. · Pubmed 23589556
  • Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA. · Pubmed 23372014
2012
  • Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. · Pubmed 22915751
  • The Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA. · Pubmed 22722202
  • Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Pubmed 22393084
2011
  • Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Pubmed 21965336
  • Massachusetts General Hospital Cancer Center, 55 Fruit Street, Laurence House, Boston, MA 02114, USA. · Pubmed 21278769
Miscellaneous institutions in Barcelona
2015
  • SOLTI Breast Cancer Research Group, Barcelona, Spain. · Medical Oncology, Arnau de Vilanova Hospital, Valencia, Spain. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Medical Oncology, University Clinic Hospital, Valencia, Spain. · Universitary Hospital of Besançon, Besançon, France. · Gustave Roussy Institute, Villejuif, France. · Medical Oncology, Arnau de Vilanova Hospital, Lleida, Spain. · Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Medical Oncology, Sant Joan de Reus Hospital, Reus, Spain. · Institut Bergonié, University of Bordeaux, INSERM U916, Bordeaux, France. · Medical Oncology, Virgen del Rocío Hospital, Sevilla, Spain. · Medical Oncology, 12 de Octubre Hospital, Madrid, Spain. · Institut Claudius Regaud, Toulouse, France. · Medical Oncology, Cáceres Hospital, Cáceres, Spain. · Medical Oncology, Valencia Oncology Institute, Valencia, Spain. · Medical Oncology, Jaen Hospital, Jaen, Spain. · Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of OB&GYN, Breast Center, University of Munich, Munich, Germany. · Sanofi Oncology Division, Cambridge, MA, USA. · Pathology Department, Jean Perrin Center, Clermont-Ferrand, France. · EA 4677 ERTICA University of Auvergne, Clermont-Ferrand, France. · Breast Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 26536871
2016
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
2013
  • Experimental Therapeutics, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 23635776
  • Preclinical Research, Vall d'Hebron Institute of Oncology (VHIO, Barcelona, Spain. · Pubmed 23288917
  • Preclinical Research Program, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 22641219
2012
  • Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, Barcelona, Spain. · Pubmed 22915752
  • Department of Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology, Pg Vall d'Hebron, Barcelona, Spain. · Pubmed 22407832
2011
  • Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 21343397
  • Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 21383049
  • Departments of Medical Oncology and Molecular Pathology, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Pubmed 21321214
  • Experimental Therapeutics Program, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 21278786
Unspecified
2014
  • 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · Medical Oncology, Nepean Hospital, Penrith, NSW, Australia. · Breast International Group Executive Board. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium [3] Breast International Group Executive Board. · Pubmed 25225904
2016
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
2015
2014
  • Authors' Affiliations: Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain · Catalan Institute of Oncology, Barcelona, Spain · Sarah Cannon Research Institute, Nashville, Tennessee · Novartis Pharmaceuticals, East Hanover, NJ · Novartis Pharmaceuticals, Florham Park, New Jersy · C.H.U. Sart-Tilman, Liege · Oncologisch Centrum AZ-St. Augustinus Oncology, Antwerp, Belgium · Novartis Pharma AG, Basel, Switzerland · Novartis Oncology, Paris, France · Memorial Sloan-Kettering Cancer Centre, New York, New York · Highlands Oncology Group, Fayetteville, Arkansas · and Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. · Pubmed 24470511
Universitat Autonoma de Barcelona
2014
  • *Authors contributed equally to this work. · *Authors contributed equally to this work.Affiliations of authors: Preclinical Research (JLPP, BM, ME, RV, MZF, KP, VS, AP, JA) and Clinical Research Programs (PN, JC, ITR), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain (VP); Human Oncology and Pathogenesis Program (HOPP) and Memorial Sloan Kettering Cancer Center, New York, NY (MS, JB); Instituto de Biología Molecular y Celular del Cáncer, Campus Miguel de Unamuno, Salamanca, Spain (AP); Lineberger Comprehensive Cancer Center, Chapel Hill, NC (CMP); Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (JA). · Pubmed 25253614
2010
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 21147694
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, Barcelona, Spain E-08035. · Pubmed 20124182
2014
  • Authors' Affiliations: Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain · Catalan Institute of Oncology, Barcelona, Spain · Sarah Cannon Research Institute, Nashville, Tennessee · Novartis Pharmaceuticals, East Hanover, NJ · Novartis Pharmaceuticals, Florham Park, New Jersy · C.H.U. Sart-Tilman, Liege · Oncologisch Centrum AZ-St. Augustinus Oncology, Antwerp, Belgium · Novartis Pharma AG, Basel, Switzerland · Novartis Oncology, Paris, France · Memorial Sloan-Kettering Cancer Centre, New York, New York · Highlands Oncology Group, Fayetteville, Arkansas · and Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. · Pubmed 24470511
  • Authors' Affiliations: Translational Genomics Group, Vall d'Hebron Institute of Oncology; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona; Hospital Clinico Universitario, Valencia, Spain; Oncologia Medica, San Raffaele Cancer Centre, Milan, Italy; Roche, Pharma Research and Early Development, Penzberg; Frauenklinik vom Roten Kreuz, Munich, Germany; University of North Carolina, Chapel Hill, North Carolina; NN Petrov Research Institute of Oncology, St Petersburg, Russian Federation; NN Blokhin Russian Cancer Centre; Central Clinical Hospital named after N A Semashko, Moscow, Russia; and Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24443618
2013
  • aVall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain bMedStar Washington Hospital Center, Washington Cancer Institute, Washington, District of Columbia cMid Ohio Oncology/Hematology Inc., The Mark H. Zangmeister Center, Columbus, Ohio dGenentech, South San Francisco, California eMemorial Sloan-Kettering Cancer Center, New York, New York, USA fRiga East University Hospital Oncology Center, Riga, Latvia gDaugavpils Reǵionālā Slimnīca, Daugavpils, Latvia hGesundheitszentrum Fricktal, Spital Rheinfelden & Laufenburg, Rheinfelden, Switzerland iNational Hospital Organization Osaka National Hospital, Osaka-City, Osaka, Japan jRoche Products Limited, Welwyn Garden City, UK kPharsight, Montreal, Quebec, Canada. · Pubmed 23969513
  • Department of Oncology, Vall D'Hebron University Hospital, Barcelona, Spain. · Pubmed 23868905
2012
  • Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 21976387
  • Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 22357447
  • Breast Cancer Center, Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 21828361
2010
  • Breast Cancer Center, Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Pubmed 20125090
  • Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 20406840
2009
  • Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 19671849
Universidad de Salamanca
2014
  • *Authors contributed equally to this work. · *Authors contributed equally to this work.Affiliations of authors: Preclinical Research (JLPP, BM, ME, RV, MZF, KP, VS, AP, JA) and Clinical Research Programs (PN, JC, ITR), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain (VP); Human Oncology and Pathogenesis Program (HOPP) and Memorial Sloan Kettering Cancer Center, New York, NY (MS, JB); Instituto de Biología Molecular y Celular del Cáncer, Campus Miguel de Unamuno, Salamanca, Spain (AP); Lineberger Comprehensive Cancer Center, Chapel Hill, NC (CMP); Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (JA). · Pubmed 25253614
62 Other Locations Show
Yearly article counts 1241714203317131230
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.